Saratoga Research & Investment Management Amgen Inc Transaction History
Saratoga Research & Investment Management
- $2.2 Billion
- Q2 2024
A detailed history of Saratoga Research & Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Saratoga Research & Investment Management holds 2,526 shares of AMGN stock, worth $819,333. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,526
Previous 2,573
1.83%
Holding current value
$819,333
Previous $731,000
7.93%
% of portfolio
0.04%
Previous 0.03%
Shares
25 transactions
Others Institutions Holding AMGN
# of Institutions
3,052Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.8 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.4 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.69 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.66 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $174B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...